Carlos A, Sekiya H, Koga S, Gatto R, Casey M, Pham N
J Neuropathol Exp Neurol. 2023; 83(1):36-52.
PMID: 38086178
PMC: 10746697.
DOI: 10.1093/jnen/nlad105.
Carlos A, Machulda M, Rutledge M, Nguyen A, Ross Reichard R, Baker M
J Alzheimers Dis. 2023; 93(4):1521-1535.
PMID: 37182869
PMC: 10923399.
DOI: 10.3233/JAD-221094.
Townley R, Syrjanen J, Botha H, Kremers W, Aakre J, Fields J
Mayo Clin Proc. 2019; 94(8):1516-1523.
PMID: 31280871
PMC: 6937135.
DOI: 10.1016/j.mayocp.2019.01.043.
Roberts R, Kang Y, Hu C, Moser C, Wang S, Moore M
J Alzheimers Dis Rep. 2018; 1(1):115-124.
PMID: 30035253
PMC: 6052874.
DOI: 10.3233/ADR-170028.
Graff-Radford J, Raman M, Rabinstein A, Przybelski S, Lesnick T, Boeve B
JAMA Neurol. 2017; 75(2):212-218.
PMID: 29204605
PMC: 5838800.
DOI: 10.1001/jamaneurol.2017.3392.
Dementia registries around the globe and their applications: A systematic review.
Krysinska K, Sachdev P, Breitner J, Kivipelto M, Kukull W, Brodaty H
Alzheimers Dement. 2017; 13(9):1031-1047.
PMID: 28576507
PMC: 6872163.
DOI: 10.1016/j.jalz.2017.04.005.
An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease.
Raman M, Schwarz C, Murray M, Lowe V, Dickson D, Jack Jr C
J Neuroimaging. 2016; 26(3):264-8.
PMID: 27017996
PMC: 4848115.
DOI: 10.1111/jon.12341.
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.
Nedelska Z, Ferman T, Boeve B, Przybelski S, Lesnick T, Murray M
Neurobiol Aging. 2014; 36(1):452-61.
PMID: 25128280
PMC: 4268128.
DOI: 10.1016/j.neurobiolaging.2014.07.005.
Antemortem MRI findings associated with microinfarcts at autopsy.
Raman M, Preboske G, Przybelski S, Gunter J, Senjem M, Vemuri P
Neurology. 2014; 82(22):1951-8.
PMID: 24793188
PMC: 4105260.
DOI: 10.1212/WNL.0000000000000471.
Risk factors for dementia with Lewy bodies: a case-control study.
Boot B, Orr C, Ahlskog J, Ferman T, Roberts R, Pankratz V
Neurology. 2013; 81(9):833-40.
PMID: 23892702
PMC: 3908463.
DOI: 10.1212/WNL.0b013e3182a2cbd1.
FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
Madhavan A, Whitwell J, Weigand S, Duffy J, Strand E, Machulda M
PLoS One. 2013; 8(4):e62471.
PMID: 23626825
PMC: 3633885.
DOI: 10.1371/journal.pone.0062471.
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell J, Dickson D, Murray M, Weigand S, Tosakulwong N, Senjem M
Lancet Neurol. 2012; 11(10):868-77.
PMID: 22951070
PMC: 3490201.
DOI: 10.1016/S1474-4422(12)70200-4.
Successful aging: definitions and prediction of longevity and conversion to mild cognitive impairment.
Negash S, Smith G, Pankratz S, Aakre J, Geda Y, Roberts R
Am J Geriatr Psychiatry. 2011; 19(6):581-8.
PMID: 21606901
PMC: 3918503.
DOI: 10.1097/JGP.0b013e3181f17ec9.
Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD.
Vemuri P, Weigand S, Knopman D, Kantarci K, Boeve B, Petersen R
Neuroimage. 2010; 54(2):985-91.
PMID: 20832487
PMC: 2997139.
DOI: 10.1016/j.neuroimage.2010.09.004.
Predicting clinical scores from magnetic resonance scans in Alzheimer's disease.
Stonnington C, Chu C, Kloppel S, Jack Jr C, Ashburner J, Frackowiak R
Neuroimage. 2010; 51(4):1405-13.
PMID: 20347044
PMC: 2871976.
DOI: 10.1016/j.neuroimage.2010.03.051.
Effects of age on the glucose metabolic changes in mild cognitive impairment.
Kantarci K, Senjem M, Lowe V, Wiste H, Weigand S, Kemp B
AJNR Am J Neuroradiol. 2010; 31(7):1247-53.
PMID: 20299441
PMC: 2890033.
DOI: 10.3174/ajnr.A2070.
Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks.
Machulda M, Senjem M, Weigand S, Smith G, Ivnik R, Boeve B
J Int Neuropsychol Soc. 2009; 15(3):372-82.
PMID: 19402923
PMC: 2762430.
DOI: 10.1017/S1355617709090523.
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
Kantarci K, Weigand S, Przybelski S, Shiung M, Whitwell J, Negash S
Neurology. 2009; 72(17):1519-25.
PMID: 19398707
PMC: 2843530.
DOI: 10.1212/WNL.0b013e3181a2e864.
Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
Kantarci K, Petersen R, Przybelski S, Weigand S, Shiung M, Whitwell J
Arch Neurol. 2008; 65(12):1621-8.
PMID: 19064749
PMC: 2743393.
DOI: 10.1001/archneur.65.12.1621.
Age and apoE associations with complex pathologic features in Alzheimer's disease.
Jicha G, Parisi J, Dickson D, Cha R, Johnson K, Smith G
J Neurol Sci. 2008; 273(1-2):34-9.
PMID: 18653200
PMC: 2569823.
DOI: 10.1016/j.jns.2008.06.008.
